AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie Inc. shares climbed 1.17% to close at $223.01 on Friday, outperforming the broader market. Investors are gearing up for the drugmaker’s upcoming earnings report next week.

31 January 2026

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares climbed roughly 1% on Friday, closing in on the session peak at $222.73 after fluctuating between $219.54 and $222.77.

30 January 2026

Earnings Reports·NASDAQ:ABBV·Pharmaceuticals·Stock Market

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

TechStock² Updates

American Airlines Shares Fall 0.6% While Carrier Adds Seven Routes, Faces 2.7% Operating Margin Pressure

PayPal Stock Falls 12.7%, Erasing $6.9 Billion as $53 Billion Bid Collapses

Circle’s $73.7 Billion USDC Gains International Visibility With Chelsea Shirt Sponsorship

Marvell Shares Drop 10.3%, Wiping Out $22 Billion After Google AI Revenue Delayed Beyond 2029

Ondas Shares Drop 9.7% After Reporting $50.6 Million EBITDA Loss Despite $757 Million Backlog

IREN shares drop 12.5% after $4 billion AI contract announcements coincide with $703 million annual loss

Nvidia Stock Falls 4.6%, Erasing $251 Billion as Margin Guide Tests AI Rally

Flutter shares climb 7.1% as FanDuel’s $350 promotion puts spotlight on marketing spend

DraftKings Bonus Incentive Drives Marketing Costs to 22% of Revenue; Shares Gain 4.3%

SpaceX Starship Flight 14 Slips to September as $1.85 Trillion Valuation Awaits Orbital Test

Investment Disclaimer